Article

Radiotherapy in painful heel spurs (plantar fasciitis)--results of a national patterns of care study.

Department of Radiotherapy, Münster University Hospital, Münster, Germany.
International Journal of Radiation OncologyBiologyPhysics (Impact Factor: 4.52). 04/2004; 58(3):828-43. DOI: 10.1016/S0360-3016(03)01620-1
Source: PubMed

ABSTRACT After a general patterns of care study, the German Cooperative Group on Radiotherapy for Benign Diseases conducted a multicenter cohort study to analyze radiotherapy (RT) in painful heel spur syndrome (HSS).
In 2001, a patterns of care study was conducted in all German RT institutions using a standardized structured questionnaire. Patient accrual, patient number, pretreatment, pain record, treatment indications, RT technique, and target volume concepts for painful HSS were assessed. In addition, the functional and subjective outcomes were evaluated.
Of the institutions, 146 (79.3%) returned the questionnaire: 10 (6.8%) reported no clinical experience with RT for HSS, and 136 (93.2%) treated 3621 patients annually, a median of 23 cases/institution. The indications for treatment were chronic or therapy refractory pain. The total dose ranged between 2.5 and 18.75 Gy (median 6), and single fractions ranged between 0.3 and 1. 5 Gy (median 1). Of the responding institutions, 44.9% applied two fractions and 37.5% three fractions weekly. RT was delivered with orthovoltage units (38.2%), linear accelerators (53.7%), (60)Co units (5.1%), or other treatment units (3%). Seventy-six institutions presented their retrospective clinical evaluation in a total of 7947 patients. Pain reduction for at least 3 months was reported in 70%, and persistent pain reduction was reported in 65% of the treated patients. In 19 institutions, a second RT series was applied for inadequate pain response or early pain recurrence. No radiogenic acute or chronic side effects were observed.
The study comprised the largest number of cases reported of RT for painful HSS. Despite variations in the daily RT practice, this national patterns of care study represents a very large number of painful and refractory HSS cases that were treated effectively with RT.

0 Bookmarks
 · 
83 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: After a patterns-of-care study (PCS) in 2003/2004 addressing benign disorders in general, the German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD) conducted several multicenter cohort studies including the use of radiotherapy (RT) in painful gonarthrosis (GNA). From 2006 to 2008, a PCS for GNA was conducted in all German RT institutions using a standardized structured questionnaire. Patient accrual, patient number, pretreatment, pain record, treatment indications, RT technique, and target volume concepts for painful GNA were assessed. In addition, the long-term functional and subjective outcomes were evaluated. 238/248 institutions (95.9%) returned the questionnaire: 50 (21%) reported no clinical experience with RT in GNA, while 188 (79%) institutions treated 4,544 patients annually (median 15; range one to 846 cases per institution). Indications for treatment were acute pain symptoms in 18.9%, chronic pain in 95.3%, and treatment-refractory pain in 81.1%. The median total dose was 6 Gy (range 3-12 Gy), with a median single dose of 1 Gy (0.25-3 Gy). 40.4% of the institutions applied two fractions and 51.4% three fractions weekly. RT was delivered with orthovoltage units (25%), linear accelerators (79.6%), and cobalt-60 units (8.3%). 42 institutions evaluated the long-term clinical outcome in a total of 5,069 cases. Median pain reduction for at least 3 months was reported in 60% (5-100%), median pain reduction for at least 12 months in 40% (10-100%), and median persistent pain reduction in 27.8% (10-85%) of the treated patients. In 30% of patients (7-100%), a second RT series was applied for inadequate pain response or early pain recurrence. No radiogenic acute or chronic side effects were observed. This PCS comprises the largest number of cases reported for RT in painful and refractory GNA. Despite variations in daily RT practice, high response and low toxicity for this treatment in a very large number of painful and refractory GNA cases renders low-dose RT an effective conservative therapy which can be applied prior to surgical procedures.
    Strahlentherapie und Onkologie 01/2010; 186(1):7-17. · 4.16 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Въведение: Ръководството се състои от две основни глави- „ Лъчелечение на нетуморните заболявания“ и „Лъчелечение на доброкачествени тумори“. След всяка от главите с Библиография. Ръководството е предназначено за широк кръг от лекари- лични лекари, редица специалисти (кожни, очни, ушни, невролози, педиатри и т.н.), разбира се и за лъчетерапевти с цел разширяване на техните познания. След обширен литературен обзор от световната практика и международно приети консенсуси, както и от нашия скромен опит, се постарахме да представим ефективното лъчелечение при доброкачествените заболявания. Нашата основна цел е чрез разширяване на познанията на медицинските специалисти да подобрим качеството на живот на много пациенти, които действително се нуждаят от качествено лъчелечение. Въпреки риска от късни лъчеви реакции (предимно от страна на кожата, карциногенеза и генетични промени) след облъчване с йонизиращи лъчения, ЛЛ продължава да е актуално, приемливо и ефикасно за редица доброкачествени заболявания. След натрупан световен опит чрез редица рандомизирани проспективни проучвания, бе отчетен траен противовъзпалителен и противоболков ефект при много възпалителни и ставнодегенеративни заболявания, както и благоприятен ефект върху ставната подвижност. Изключително важно е трайното лъчелечебно подобряване на качеството на живот при много пациенти. Високата лъчерезистентност на доброкачествените тумори, често налага ЛЛ на малки туморни обеми (КМО) с високи канцерицидни дози (достатъчни за унищожаване на диференцираната туморна клетка). Лъчелечението се базира на подобни на онкологичните лъчетерапевтични изисвания и стандарти. Голяма част от доброкачествените тумори са дълбоко разположени, факт изискващ високоенергийно фотонно ЛЛ, генерирано от линеен ускорител. За максимална защита на околните нормални тъкани и органи, се налага конформално ЛЛ с модерна високоенергийна лъчетерапевична апаратура –ускорител или гаманайф, прилагане на високотехнологични лъчетерапевтични режими- стереотактично лъчелечение, три-D конформално ЛЛ и интензивно модулирано ЛЛ. Основната цел при ЛЛ на доброкачествените тумори е подтискане на клетъчната пролиферация, което определя ДОД – от 1,8-3 Gy и общата огнищна доза (ООД) 45-60Gy. Целта е постигане на туморна ерадикация или спиране на туморния растеж при значимо минимизиране на късната детерминирана лъчева токсичност на нормалните тъкани и органи.
    Галакта- Колор принт edited by Доц. д-р Лена Маринова,дмн, 05/2010; , ISBN: 978-957-92254-5-7
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Painful plantar heel spur (PPHS) is a benign disorder with painful heels as a result of plantar calcaneal bone spur. Exact etiological factors are still unclear. Treatment typically consists of osteoarthritis tretment schedules and surgical techniques. External radiotherapy is another treatment option. This study is aimed to determine effectiveness and treatment outcomes of external radiotherapy in patients with PPHS. Sixty-two patients with PPHS were analysed for radiotherapy success and other possible prognostic factors. All patients were treated with Co-60 units from parallel opposed lateral portals, to a total dose of 8 Gy. Responses to radiotherapy was assessed by visual analogue scale (VAS) of pain. Follow-up completed in December 2012 with 28 months median duration (range 22 to 35 months). Age, sex, patient number, spur settlement site, prior treatments, time interval between diagnosis and radiotherapy, pain scores (before and after radiotherapy), plantar fat-pillow thickness (PFPT; thickness of the plantar fat pad) and Böhler's angle estimations were analysed. Study included 53 female and 9 male patients with median age 57 (range 43-70). Time interval between PPHS diagnosis and radiotherapy were median 33 months (range10-60). Radiotherapy response time interval were 6 months (range 3-10 months). Responses to radiotherapy were no response in 13 patients (21%), partial response in 13 patients (21%)- pain relief below 50% and complete response - no pain in 36 patients (58%) respectively. Median PFPT of patients were 3.5 cm (range 1.20-4.50 cm). Complete response rate was statistically significant in patients whom PFPT is greater than 3.5 cm. The Böhler's angle range is about 20-40 deg. Complete response rates were higher in patients with degree of Böhler's Angle 30 and below. Simplicity of treatment, lack of acute adverse effects and low cost, seem to make radiotherapy one of the safest, cheapest and also an effective treatment modality for PPHS.
    SpringerPlus 01/2014; 3:21.

Full-text (2 Sources)

View
294 Downloads
Available from
Jun 4, 2014